Great Point Partners Llc Portfolio Stock Holdings
Great Point Partners Llc disclosed 39 stock positions valued at approximately $408.3 million in its latest SEC 13F filing. The largest holdings include APOGEE THERAPEUTICS INC, AMYLYX PHARMACEUTICALS INC, and ALUMIS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 39
- Portfolio Value
- $408.3M
Holdings by Sector
Great Point Partners Llc Portfolio Holdings in Q1 2026
25 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| APOGEE THERAPEUTICS INC | APGE | Healthcare | 7.71% | 374,000 | - | - | $31,479,580 |
| AMYLYX PHARMACEUTICALS INC | AMLX | Healthcare | 5.96% | 1,750,000 | - | - | $24,325,000 |
| ALUMIS INC | ALMS | Healthcare | 4.62% | 856,061 | +856,061 | +100.00% | $18,859,024 |
| ANNEXON INC | ANNX | Healthcare | 3.39% | 2,500,000 | +2,500,000 | +100.00% | $13,850,000 |
| KALVISTA PHARMACEUTICALS INC | KALV | Healthcare | 3.33% | 675,000 | -10,632 | -1.55% | $13,587,750 |
| IMMUNOVANT INC | IMVT | Healthcare | 3.32% | 545,625 | -204,375 | -27.25% | $13,553,325 |
| CONTINEUM THERAPEUTICS INC | CTNM | Healthcare | 2.56% | 800,198 | +198 | +0.02% | $10,450,586 |
| NEUROGENE INC | NGNE | Healthcare | 2.47% | 500,000 | +150,000 | +42.86% | $10,080,000 |
| MOONLAKE IMMUNOTHERAPEUTICS | MLTX | Healthcare | 2.28% | 500,000 | +500,000 | +100.00% | $9,320,000 |
| CLIMB BIO INC | ELYM | Other | 2.24% | 1,334,130 | +354,596 | +36.20% | $9,138,791 |
| VERA THERAPEUTICS INC | VERA | Healthcare | 1.96% | 199,348 | +199,348 | +100.00% | $8,019,770 |
| COMPASS THERAPEUTICS INC | CMPX | Healthcare | 1.75% | 1,350,000 | +1,350,000 | +100.00% | $7,141,500 |
| SCYNEXIS INC | SCYX | Healthcare | 1.70% | 7,554,347 | +7,554,347 | +100.00% | $6,926,581 |
| CONTEXT THERAPEUTICS INC | CNTX | Healthcare | 1.44% | 2,238,496 | -2,445,215 | -52.21% | $5,864,860 |
| RELMADA THERAPEUTICS INC | RLMD | Healthcare | 1.44% | 842,106 | +842,106 | +100.00% | $5,861,058 |
| SILENCE THERAPEUTICS PLC | SLN | Healthcare | 1.32% | 1,020,489 | +212,457 | +26.29% | $5,377,977 |
| TENAX THERAPEUTICS INC | TENX | Healthcare | 1.28% | 327,307 | +327,307 | +100.00% | $5,233,639 |
| CULLINAN THERAPEUTICS INC | CGEM | Healthcare | 1.04% | 300,000 | -334,032 | -52.68% | $4,263,000 |
| IMMIX BIOPHARMA INC | IMMX | Healthcare | 0.78% | 350,000 | +350,000 | +100.00% | $3,188,500 |
| REZOLUTE INC | RZLT | Healthcare | 0.71% | 951,809 | - | - | $2,903,017 |
| PHARVARIS N V | PHVS | Other | 0.57% | 82,800 | - | - | $2,339,100 |
| HUMACYTE INC | HUMA | Healthcare | 0.56% | 3,750,000 | +3,750,000 | +100.00% | $2,275,125 |
| AVALO THERAPEUTICS INC | AVTX | Healthcare | 0.46% | 124,666 | - | - | $1,861,263 |
| ALKERMES PLC | G01767105 | Other | 0.43% | 50,000 | +50,000 | +100.00% | $1,768,000 |
| OPUS GENETICS INC | OCUP | Other | 0.36% | 324,340 | +324,340 | +100.00% | $1,475,747 |
Great Point Partners Llc Options Holdings in Q1 2026
3 options positions in the latest reporting period.
Page 1 of 1
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q1 2026 | IBRX | ImmunityBio, Inc. | PUT | 3,000,800 | $23,016,136 |
| Q1 2026 | GALT | Galectin Therapeutics Inc. | CALL | 800,000 | $2,232,000 |
| Q1 2026 | AVXL | Anavex Life Sciences Corp. | CALL | 521,300 | $1,600,391 |
Notional value represents the total exposure of the options position.